Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea

NCT00891371 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ipsen